Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients: a single-arm, multicenter phase II study (INTELLECT)Yuankai Shi, Xiaoyan Kang, Jianhua Chen et al.|BMC Medicine|2023Cited by 24
SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancerJun Zhao, Yi‐Long Wu, Xinmin Yu et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 21
Distribution of uridine diphosphate glucuronosyltransferase 1A polymorphisms and their role in irinotecan‑induced toxicity in patients with cancerYang Wang, Xiuwen Wang, Cuihua Yi et al.|Oncology Letters|2017Cited by 11
Modified transoral endoscopic thyroid surgery for treatment of thyroid cancer: operative steps and videoXiaowei Peng, Wen Peng, Hui Li et al.|Gland Surgery|2017Cited by 8
251 Efficacy and safety of iparomlimab and tuvonralimab in previously treated patients with recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase 2 clinical trial (DUBHE-C-206)Hanmei Lou, Jihong Liu, Yun Zhou et al.|International Journal of Gynecological Cancer|2024Cited by 5